福多司坦治疗慢性阻塞性肺疾病稳定期的临床观察  

Clinical observation of effect of Fudosteine on treating chronic obstructive pulmonary disease during stable stage

作　　者：李红苗[1] 蒋冬兰[1] 沈文富[1] LI Hongmiao;JIANG Donglan;SHEN Wenfu(People’s Hospital of Jianhu City,yancheng224700)

机构地区：[1]建湖县人民医院呼吸科,江苏盐城224700

出　　处：《世界中医药》2017年第A02期117-118,共2页World Chinese Medicine

摘　　要：目的 探讨福多司坦治疗慢性阻塞性肺疾病稳定期的临床疗效。方法 90例慢性阻塞性肺疾病稳定期患者随机分为对照组及治疗组，对照组（45例）常规予以长期家庭氧疗、呼吸肌功能锻炼、营养支持、吸入药物等治疗外，治疗组（45例）在此基础上口服福多司坦药物六个月。动态观察并比较两组患者的临床症状改善情况及肺功能变化。结果 两组治疗后临床症状均有明显改善，治疗组治疗后临床症状较对照组治疗后有明显改善。结论Objective To observe the clinical effect of Fudosteine on treating chronic obstructive pulmonary disease(COPD)during stable stage.Methods90patients with chronic obstructive pulmonary disease during stable stage were randomly divided into control group and treatment group.Patients in control group were treated with long-time home oxygen therapy、respiratory muscles exercises、nutrition support、inhaled remedies,patients in treatment group were treated with fudosteine,and compared the curative effects of the two groups after treating for6months.Result Compared with before treating,the clinical symptoms of two groups after treating were dramatically improved.Compared with control group after treating,the clinical symptoms of treatment group after treating were dramatically improved.Conclusion The curative effect of treating patients with COPD during stable stage is significant.

关 键 词：福多司坦 慢性阻塞性肺疾病 临床症状 

分 类 号：R256.212[医药卫生—中医内科学]